C4 Therapeutics, Inc.
CCCC- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001662579
No open-market purchases or sales by C4 Therapeutics, Inc. insiders were filed in the last 90 days; 147 institutions reported holding it in 13F filings for Q2 2026, worth $547.6M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in C4 Therapeutics, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 114
- +1 vs. Q2 2022
- Shares held
- 39.4M
- +4.51K (0.0%) vs. Q2 2022
- Total value
- $345.9M
- +$48.7M (+16.4%) vs. Q2 2022
- New holders
- 17
- 46 more added
- Sold out
- 16
- 32 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CCCC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 147 | $547.6M |
| Q1 2026 | 123 | $221.3M |
| Q4 2025 | 101 | $152.5M |
| Q3 2025 | 97 | $116.6M |
| Q2 2025 | 102 | $78.2M |
| Q1 2025 | 115 | $102.6M |
| Q4 2024 | 113 | $231.8M |
| Q3 2024 | 118 | $365.9M |
| Q2 2024 | 115 | $281.3M |
| Q1 2024 | 106 | $475.6M |
| Q4 2023 | 92 | $265.6M |
| Q3 2023 | 84 | $64.5M |
| Q2 2023 | 100 | $94.1M |
| Q1 2023 | 121 | $117.5M |
| Q4 2022 | 117 | $231.4M |
| Q3 2022 | 114 | $345.9M |
| Q2 2022 | 113 | $297.2M |
| Q1 2022 | 125 | $904.8M |
| Q4 2021 | 119 | $1.15B |
| Q3 2021 | 113 | $1.54B |
| Q2 2021 | 107 | $1.21B |
| Q1 2021 | 83 | $926.8M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding C4 Therapeutics, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Jacobs Levy Equity Management, Inc | 738,993 | $6.48M | 0.05% | +206,573+38.8% | Added |
| Perceptive Advisors LLC | 766,231 | $6.72M | 0.20% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 777,222 | $6.82M | 0.00% | +55,797+7.7% | Added |
| Janus Henderson Group PLC | 818,747 | $7.18M | 0.01% | −30,853−3.6% | Reduced |
| Pictet Asset Management SA | 1,305,349 | $11.4M | 0.02% | +168,495+14.8% | Added |
| Soleus Capital Management, L.P. | 1,441,513 | $12.6M | 1.72% | +1,158,873+410.0% | Added |
| Bain Capital Life Sciences Investors, LLC | 1,642,210 | $14.4M | 1.72% | 00.0% | Unchanged |
| State Street Corp | 1,961,812 | $17.2M | 0.00% | +1,245,369+173.8% | Added |
| Vanguard Group Inc | 2,019,654 | $17.7M | 0.00% | +58,941+3.0% | Added |
| RTW Investments, LP | 2,819,472 | $24.7M | 0.57% | −275,353−8.9% | Reduced |
| Price T Rowe Associates Inc | 2,964,056 | $26.0M | 0.00% | −1,419,107−32.4% | Reduced |
| BlackRock Inc. | 3,464,572 | $30.4M | 0.00% | +66,974+2.0% | Added |
| ArrowMark Colorado Holdings LLC | 5,091,975 | $44.7M | 0.55% | −750,432−12.8% | Reduced |
| Wasatch Advisors Inc | 5,934,476 | $52.0M | 0.36% | +267,818+4.7% | Added |
| Sphera Funds Management Ltd. | 0 | $0 | 0.00% | −705,736−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −425,647−100.0% | Sold out |
| Marshall Wace, LLP | 0 | $0 | 0.00% | −252,326−100.0% | Sold out |
| Paradigm Biocapital Advisors LP | 0 | $0 | 0.00% | −73,149−100.0% | Sold out |
| TriaGen Wealth Management LLC | 0 | $0 | 0.00% | −54,424−100.0% | Sold out |
| Ergoteles LLC | 0 | $0 | 0.00% | −43,500−100.0% | Sold out |
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −35,197−100.0% | Sold out |
| PKO Investment Management Joint-Stock Co | 0 | $0 | 0.00% | −35,000−100.0% | Sold out |
| Dynamic Technology Lab Private Ltd | 0 | $0 | 0.00% | −32,933−100.0% | Sold out |
| Atom Investors LP | 0 | $0 | 0.00% | −27,512−100.0% | Sold out |
| Jump Financial, LLC | 0 | $0 | 0.00% | −18,721−100.0% | Sold out |
| Bridgefront Capital, LLC | 0 | $0 | 0.00% | −15,925−100.0% | Sold out |
| Aj Wealth Strategies, LLC | 0 | $0 | 0.00% | −10,007−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −3,148−100.0% | Sold out |
| Dark Forest Capital Management LP | 0 | $0 | 0.00% | −303−100.0% | Sold out |
| Caption Management, LLC | 0 | $0 | 0.00% | −16−100.0% | Sold out |